|
⚲
|
| Keyboard |
| NeoMed Innovation V Ltd
✚
|
|
|---|---|
| CIK # | 0001722666 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001722666] | |
| 4 | [0001722666] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NeoMed Innovation V Ltd | |
| NeoMed Innovation V LP | |
| Axonics Inc | |
| X4 Pharmaceuticals Inc | |
| NeoMed Management Jersey Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Axonics Inc AXNX
Series A Preferred Stock · derivative
|
2018-11-02 | Conversion | 195,000 | $0.00 | |
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 451,738 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 455,610 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 243,750 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 369,786 | ||
|
Axonics Inc AXNX
Series B-1 Preferred Stock · derivative
|
2018-11-02 | Conversion | 379,675 | $0.00 | |
|
Axonics Inc AXNX
Series B-2 Preferred Stock · derivative
|
2018-11-02 | Conversion | 203,125 | $0.00 | |
|
Axonics Inc AXNX
Series C Preferred Stock · derivative
|
2018-11-02 | Conversion | 308,155 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Buy | 300,000 | $10.00 | 3,000,000 |
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 279,079 | ||
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 41,878 | ||
|
X4 Pharmaceuticals Inc ASNS
Series C Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 84,040 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 952,497 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Series B Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 552,487 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 246,682 |